Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
InnaMed
HomeLab is a company that brings personalized healthcare to your doorstep.
Sector
Subsector
Keywords
Location
total rounds
total raised
iHealth Labs
iHealth is a medical supply company that designs and manufactures innovative, consumer-friendly healthcare products.
Sector
Subsector
Location
total rounds
total raised
Decision Diagnostics
Decision Diagnostics Corp. develops smart phone-based products that provide physicians with essential information at the point of care.
Sector
Subsector
Location
total rounds
total raised
HealthCubed
HealthCubed is an electronic health diagnostic company that manufactures and provides health diagnostic products and services.
Sector
Subsector
Location
total rounds
Financials
Funding Rounds12
Number of Funding Rounds
Money Raised
Their latest funding was raised on 06.01.2022. Their latest investor Highway1. Their latest round Grant
Biomedical Advanced Research and Development Authority (BARDA)
BARDA develops and purchases vaccines, drugs, therapies, and diagnostic tools for emergencies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
U.S. Department of Defense
The U.S. Department of Defense provides military forces to deter war and protect national security.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
U.S. Department of Health & Human Services
The U.S. Department of Health & Human Services promotes the health and well-being of Americans through effective health and human services.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors27
Number of lead investors
Number of investors
Highway1
Highway1 is an accelerator firm that helps hardware startups overcome barriers to design, manufacturing, distribution and retail.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Cove Investments
Cove Investments is a global investment advisor specializing in value and special situations.
Sector
Subsector
Keywords
count Of Investments
Biomedical Advanced Research and Development Authority (BARDA)
BARDA develops and purchases vaccines, drugs, therapies, and diagnostic tools for emergencies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Rick Bright
Rick Bright, Ph.D., is director of the Biomedical Advanced Research and Development Authority (BARDA) and acting Deputy Assistant Secretary in the Office of the Assistant Secretary for Preparedness and Response within HHS. BARDA develops and provides medical countermeasures to man-made and natural threats including chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases. BARDA meets this mission by supporting product innovation, advanced development, acquisition and stockpiling, and building manufacturing infrastructure. Dr. Bright previously served as Director of the Influenza and Emerging Infectious Diseases Division in the BARDA where he was responsible for preparing the nation for influenza pandemics and coordinating production, acquisition, and delivery of medical countermeasures during a pandemic response. In this role, he managed a portfolio of projects for advanced development of vaccines, therapeutics, diagnostics, and respirator devices to aid in the response and protection against pandemic and seasonal influenza. Dr. Bright joined BARDA in 2010 to lead the BARDA Influenza Division International Program, supporting programs to build and enhance global capacity for influenza vaccine production and evaluation in developing countries. Dr. Bright serves as an international subject matter expert on influenza, vaccines and therapeutics development and diagnostic programs. He has also served as an advisor to the World Health Organization and the US Department of Defense. Dr. Bright began his career in influenza vaccine and therapeutics development at the U.S. Centers for Disease Control and Prevention, Influenza Division. At the CDC, he focused on avian and human viruses from multiple perspectives including immunology and vaccine development, viral pathogenesis and molecular correlates of pathogenicity, as well as antiviral drugs and development novel assays for high throughput surveillance for resistance to antiviral drugs. Dr. Bright was a recipient of the Charles C. Shepard Science Award for Scientific Excellence. Dr. Bright has also worked in the biotechnology industry where he serves as the Director of Immunology at Altea Therapeutics and Vice President of Research and Development and Global Influenza Programs at Novavax, Inc. In 2008, Dr. Bright joined PATH as the Scientific Director of the Influenza Vaccine Project in the Vaccine Development Global Program and the Director of the Influenza Vaccine Capacity Building Project in Vietnam. In this capacity, he provided technical leadership to accelerate the development of innovative vaccine and adjuvant candidates against influenza to ensure protection and access to vaccines for populations of developing countries. Dr. Bright received his Ph.D. in Immunology and Molecular Pathogenesis from Emory University (Atlanta, GA) and his BS in Biology (Medical Technology) and Physical Sciences from Auburn University (Montgomery, AL).
current job
People
Founders2
Ayub Khattak
Ayub Khattak is the CEO and founder at Cue.
current job
organization founded
Ayub Khattak
Employee Profiles21
Tony Medrano
Vice President of Business Development
Activity
Recent News10
The graph reveals the ratio (%) of positive news articles in a chosen time range